We welcome the following article types: original research, theories and opinions, updates, mini reviews or reviews
[6] Stephens, F
Molecular basis for the N-terminal bromodomain-and-extra-terminal-family selectivity of a dual kinasebromodomain inhibitor
Reactions of interest included dyspnoea, asthma, chronic obstructive pulmonary disease (COPD), obstructive airways disease (OAD), wheezing, cough, bronchospasm, asthma-chronic obstructive pulmonary disease, alveolar lung disease, emphysema, combined pulmonary fibrosis and emphysema, idiopathic pulmonary fibrosis (IPF), irregular breathing, respiration abnormal, productive cough or respiratory disorder
Mainly, I wanted to know whether it is even possible for GLP-1 drugs to have already lowered the national rate of obesity in the United States